OUTCOMES OF PATIENTS IN REMISSION WITH INFLAMMATORY BOWEL DISEASE WITH UNDETECTABLE INFLIXIMAB TROUGH LEVELS AND POSITIVE ANTIBODIES TO INFLIXIMAB.

Conference
25th UEG Week 2017


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing